Tetrahydroaminoacridine in Alzheimer's d
✍
A. Åhlin; H. Nybäck; T. Junthe; G. Öhman; I. Nordgren
📂
Article
📅
1991
🏛
John Wiley and Sons
🌐
English
⚖ 839 KB
The cognitive decline in Alzheimer's disease has been shown to correlate with deficits in central cholinergic neurotransmission. Among various treatment attempts using cholinergic drugs a trial of the cholinesterase inhibitor tetrahydroaminoacridine (THA) (Summers et al., 1986) attracted considerabl